TY - JOUR AU - Barlow, Russell AU - DeBess, Emilio AU - Winthrop, Kevin AU - Lapidus, Jodi AU - Vega, Robert AU - Cieslak, Paul T1 - Travel-associated Antimicrobial Drug–Resistant Nontyphoidal Salmonellae, 2004–2009 T2 - Emerging Infectious Disease journal PY - 2014 VL - 20 IS - 4 SP - 603 SN - 1080-6059 AB - To evaluate trends in and risk factors for acquisition of antimicrobial-drug resistant nontyphoidal Salmonella infections, we searched Oregon surveillance data for 2004–2009 for all culture-confirmed cases of salmonellosis. We defined clinically important resistance (CIR) as decreased susceptibility to ampicillin, ceftriaxone, ciprofloxacin, gentamicin, or trimethoprim/sulfamethoxazole. Of 2,153 cases, 2,127 (99%) nontyphoidal Salmonella isolates were obtained from a specific source (e.g., feces, urine, blood, or other normally sterile tissue) and had been tested for drug susceptibility. Among these, 347 (16%) isolates had CIR. The odds of acquiring CIR infection significantly increased each year. Hospitalization was more likely for patients with than without CIR infections. Among patients with isolates that had been tested, we analyzed data from 1,813 (84%) who were interviewed. Travel to eastern or Southeast Asia was associated with increased CIR. Isolates associated with outbreaks were less likely to have CIR. Future surveillance activities should evaluate resistance with respect to international travel. KW - Salmonella KW - drug resistance KW - foodborne diseases KW - communicable diseases KW - emerging KW - bacteria KW - Asia KW - travel KW - nontyphoidal KW - Food Safety DO - 10.3201/eid2004.131063 UR - https://wwwnc.cdc.gov/eid/article/20/4/13-1063_article ER - End of Reference